Bristol Myers's most recent trend suggests a bullish bias. One trading opportunity on Bristol Myers is a Bull Put Spread using a strike $49.00 short put and a strike $44.00 long put offers a potential 17.1% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $49.00 by expiration. The full premium credit of $0.73 would be kept by the premium seller. The risk of $4.27 would be incurred if the stock dropped below the $44.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Bristol Myers is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Bristol Myers is bullish.
The RSI indicator is at 46.95 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Bristol Myers
Bristol-Myers, Samsung BioLogics Extend Ties
Wed, 23 Apr 2014 20:30:06 GMT
Say Hello to the New Fastest Growing Drug in History!
Wed, 23 Apr 2014 14:04:09 GMT
Bristol-Myers Squibb: Great Dividend Stocks From The Bond Refugee Screen – High Yields And Low Volatility Part VI
Wed, 23 Apr 2014 11:42:12 GMT
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement
Wed, 23 Apr 2014 00:12:58 GMT
noodls – “It represents another significant step for Samsung and Bristol-Myers Squibb in strengthening our biopharmaceutical manufacturing relationship.” NEW YORK & SEOUL, South Korea–(BUSINESS WIRE)–Bristol-Myers …
Bristol-Myers and Samsung BioLogics to increase scope of existing agreement
Tue, 22 Apr 2014 23:03:52 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook